173 related articles for article (PubMed ID: 8873436)
21. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation.
Schnuelle P; Lorenz D; Mueller A; Trede M; Van Der Woude FJ
Kidney Int; 1999 Aug; 56(2):738-46. PubMed ID: 10432416
[TBL] [Abstract][Full Text] [Related]
22. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
23. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
[TBL] [Abstract][Full Text] [Related]
24. The influence of acute rejection on long-term renal allograft survival: a comparison of living and cadaveric donor transplantation.
Knight RJ; Burrows L; Bodian C
Transplantation; 2001 Jul; 72(1):69-76. PubMed ID: 11468537
[TBL] [Abstract][Full Text] [Related]
25. Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up.
Shaffer D; Simpson MA; Madras PN; Sahyoun AI; Conway PA; Davis CP; Monaco AP
Arch Surg; 1995 Mar; 130(3):283-7; discussion 287-8. PubMed ID: 7887795
[TBL] [Abstract][Full Text] [Related]
26. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
27. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
[TBL] [Abstract][Full Text] [Related]
28. Renal graft survival in children with early acute rejection.
Muñoz R; Romero B; Medeiros M; Zaragoza L
Pediatr Transplant; 1998 Nov; 2(4):294-8. PubMed ID: 10084732
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
[TBL] [Abstract][Full Text] [Related]
31. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?
Marcén R; Pascual J; Teruel JL; Villafruela JJ; Rivera ME; Mampaso F; Burgos FJ; Ortuño J
Transplantation; 2001 Jul; 72(1):57-62. PubMed ID: 11468535
[TBL] [Abstract][Full Text] [Related]
32. The UNOS Scientific Renal Transplant Registry.
Cecka JM
Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
[TBL] [Abstract][Full Text] [Related]
33. Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival.
Jiang H; Sakuma S; Fujii Y; Akiyama Y; Ogawa T; Tamura K; Kobayashi M; Fujitsu T
Transpl Int; 1999; 12(2):92-9. PubMed ID: 10363590
[TBL] [Abstract][Full Text] [Related]
34. Intermediate-term outcome of renal retransplants in the cyclosporine era.
Sumrani NB; Miles AM; Daskalakis P; Hong JH; Markell MS; Friedman EA; Sommer BG
ASAIO J; 1993; 39(1):47-50. PubMed ID: 8439680
[TBL] [Abstract][Full Text] [Related]
35. Long-term graft outcome of living donor renal transplantation: single center experience.
Kwon OJ; Kim YH; Ahn BK; Kang CM; Kwak JY
Transplant Proc; 2005 Mar; 37(2):690-2. PubMed ID: 15848503
[TBL] [Abstract][Full Text] [Related]
36. [Antigraft response in advanced age cadaveric renal recipients].
Rainiene T
Medicina (Kaunas); 2002; 38 Suppl 1():84-8. PubMed ID: 12556643
[TBL] [Abstract][Full Text] [Related]
37. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporine in renal transplantation: a Scottish experience.
Jardine AG; Geddes CC
Transplant Proc; 2004 Mar; 36(2 Suppl):139S-142S. PubMed ID: 15041324
[TBL] [Abstract][Full Text] [Related]
39. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
Cecka JM
Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
[TBL] [Abstract][Full Text] [Related]
40. Neoral use in the cardiac transplant recipient.
Valantine H
Transplant Proc; 2000 May; 32(3A Suppl):27S-44S. PubMed ID: 10814748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
